Pomezia, Italy

Vincenzo Colangeli

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincenzo Colangeli. Retrieved from https://idiyas.com/inventor/vincenzo-colangeli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincenzo Colangeli: Innovator in Pharmaceutical Synthesis

Introduction

Vincenzo Colangeli is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. His work is characterized by a focus on purity and efficacy in drug development.

Latest Patents

Colangeli holds a patent for a process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline. This invention provides a new method for synthesizing a polymorph of this quinoline compound, ensuring it is substantially free of impurities. The polymorph has important applications in the synthesis of piperaquine and its pharmaceutically acceptable salts.

Career Highlights

Vincenzo Colangeli is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he has been instrumental in advancing pharmaceutical research. His innovative approaches have contributed to the development of new therapeutic agents.

Collaborations

Colangeli has worked alongside esteemed colleagues such as Walter Cabri and Roberto Castagnani. Their collaborative efforts have further enhanced the research and development capabilities within their organization.

Conclusion

Vincenzo Colangeli's contributions to pharmaceutical synthesis exemplify the importance of innovation in drug development. His work not only advances scientific knowledge but also has practical implications for improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…